Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice.

Abstract

Liver cirrhosis involves chronic wound healing and fibrotic processes. Mesenchymal stromal cells (MSCs) are multipotent adult progenitor cells that are used as vehicles of therapeutic genes. Insulin growth factor like-I (IGF-I) was shown to counteract liver fibrosis. We aimed at analyzing the effect of applying IGF-I overexpressing mouse bone marrow-derived MSCs on hepatic fibrosis. Fibrosis was induced by chronic thioacetamide application or bile duct ligation. MSCs engineered to produce green fluorescent protein (GFP) (AdGFP-MSCs) or IGF-I (AdIGF-I-MSCs) were applied systemically, and changes in collagen deposition and in the expression of key pro-fibrogenic and pro-regenerative genes/proteins were assessed. In addition, immunogenicity of transduced cells was analyzed. Liver fibrosis was further ameliorated after a single-dose application of AdIGF-I-MSCs when compared with AdGFP-MSCs and/or recombinant IGF-I treatments. Interestingly, an early and transitory upregulation in IGF-I and hepatocyte growth factor (HGF) mRNA expression was found in the liver of MSC-treated animals, which was more pronounced in AdIGF-I-MSCs condition. A reduction in hepatic stellate cell activation status was found after incubation with MSCs conditioned media. In addition, the AdIGF-I-MSCs cell-free supernatant induced the expression of IGF-I and HGF in primary cultured hepatocytes. From day 1 after transplantation, the proliferation marker proliferating cell nuclear antigen was upregulated in the liver of AdIGF-I-MSCs group, mainly in hepatocytes. MSCs were in vivo traced till day 14 after injection. In addition, multiple doses of Ad-IGF-I-MSCs likely suppressed antiviral immune response and it further reduced collagen deposition. Our results uncover early events that are likely involved in the anti-fibrogenic effect of genetically modified MSCs and overall would support the use of AdIGF-I-MSCs in treatment of liver fibrosis.

• Authors: Esteban J Fiore, Juan M Bayo, Mariana G Garcia, Mariana Malvicini, Rodrigo Lloyd, Flavia Piccioni, Manglio Rizzo, Estanislao Peixoto, M Beatriz Sola, Catalina Atorrasagasti, Laura Alaniz, María A Camilletti, Mónica Enguita, Jesús Prieto, Jorge B Aquino, Guillermo Mazzolini
• Journal: Stem cells and development (Stem Cells Dev) Vol. 24 Issue 6 Pg. 791-801 (Mar 15 2015) ISSN: 1557-8534 [Electronic] United States
• PMID: 25315017 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Insulin-Like Growth Factor I

Topics

• Adenoviridae (genetics)
• Animals
• Cell Proliferation
• Fibrosis (therapy)
• Genetic Therapy
• Hepatic Stellate Cells (metabolism, physiology)
• Hepatocytes (metabolism, physiology)
• Insulin-Like Growth Factor I (genetics, metabolism)
• Liver (pathology)
• Liver Cirrhosis (therapy)
• Male
• Mesenchymal Stem Cell Transplantation
• Mesenchymal Stem Cells (metabolism, physiology)
• Mice
• Mice, Inbred BALB C